Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01719666
Other study ID # 2010.651
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 22, 2011
Est. completion date November 2024

Study information

Verified date March 2023
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesis is lateral retinaculum release has no effect on treatment of Patellar Recurrent Dislocation with Medial Patellofemoral Ligament (MPFL) reconstruction.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 140
Est. completion date November 2024
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - age between 18yo and 45yo - indication for MPFL reconstruction - unilateral or bilateral indication Exclusion Criteria: - indication for bony procedures - previous surgery for PF disorders - patient refusal

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
MPFL reconstruction and lateral retinaculum release
MPFL is performed with a standard technique using gracilis tendon. A tunnel is performed at the femoral part with a bioabsorbable screw fixation and 2 bundles with suture fixation at the patellar side
conventional surgery
conventional surgery: MPFL reconstruction

Locations

Country Name City State
France Croix-Rousse Hospital, Hospices Civils de Lyon Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patellar tilt measurement IKDC score, patellar tilt measurement on x-rays and CT-scan 2 years of follow up
Secondary rate of complications 2 years of follow up